Ligand validation:8RVX

CYC: PHYCOCYANOBILIN

CYC is a Ligand Of Interest in 8RVX designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8RVX_CYC_A_601	63%	15%	0.143	0.938	2.24	1.54	12	13	9	0	100%	1
8RVX_CYC_D_601	53%	16%	0.163	0.923	2.23	1.51	13	9	7	0	100%	1
8RVX_CYC_B_601	43%	19%	0.169	0.891	2.06	1.4	11	10	8	0	100%	1
8RVX_CYC_C_601	40%	16%	0.188	0.897	2.24	1.51	10	7	9	0	100%	1
3ZQ5_CYC_A_1521	69%	2%	0.138	0.952	3.68	3.18	16	19	6	0	100%	1
2VEA_CYC_A_1521	40%	2%	0.158	0.868	3.78	3.18	16	24	16	0	100%	1
4YJJ_CYC_B_202	100%	3%	0.022	0.996	3.2	2.83	15	22	19	0	100%	1
1EYX_CYC_B_181	100%	4%	0.028	0.994	3.03	2.52	14	18	4	0	100%	1
4H0M_CYC_I_201	100%	4%	0.027	0.992	2.27	3.46	15	22	10	0	100%	1
3L0F_CYC_A_484	100%	6%	0.038	0.981	2.08	3.03	10	21	2	0	100%	1
4Q70_CYC_A_201	98%	21%	0.049	0.973	1.83	1.47	14	6	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.